Literature DB >> 14766417

Extracellular virulence factors of Streptococcus pneumoniae.

Mark J Jedrzejas1.   

Abstract

Streptococcus pneumoniae is one of the major human bacterial pathogens. Current prophylactic agents against this pathogen are limited in their protective abilities and the role of therapeutics has been inadequate as resistant strains emerge. The development of new and improved therapies to combat the pneumococcal disease is necessary. In order to accomplish this, an understanding of the interactions between this bacterium and the host tissues is essential. Such interactions largely involve extracellular virulence factors that are expressed by the pathogen to interact with the host. These virulence factors include those based on sugars (glycome-based) as their building blocks, and proteins that are built from amino acids (proteome-based). The first group includes primarily the capsule, teichoic and lipoteichoic acids. The second group is diverse and includes numerous surface proteins that are attached to the cell wall of pneumococci utilizing a variety of methods. For the purpose of this review these surface proteins were divided into three categories, proteins bound to peptidoglycan, those bound to choline residues present on the surface of penumococci, and those bound to the lipids of the cytoplasmic membrane. Both the glycome-based and protein-based virulence factors are described, analyzed, and represented graphically. Whenever possible, structural properties of these molecules were introduced.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766417     DOI: 10.2741/1299

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

1.  Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.

Authors:  Lauren J McAllister; Abiodun D Ogunniyi; Uwe H Stroeher; Amanda J Leach; James C Paton
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 2.  Hyaluronidases: their genomics, structures, and mechanisms of action.

Authors:  Robert Stern; Mark J Jedrzejas
Journal:  Chem Rev       Date:  2006-03       Impact factor: 60.622

3.  Differential idiotype utilization for the in vivo type 14 capsular polysaccharide-specific Ig responses to intact Streptococcus pneumoniae versus a pneumococcal conjugate vaccine.

Authors:  Jesus Colino; Leah Duke; Swadhinya Arjunaraja; Quanyi Chen; Leyu Liu; Alexander H Lucas; Clifford M Snapper
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

4.  The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domain.

Authors:  Swadhinya Arjunaraja; Paola Massari; Lee M Wetzler; Andrew Lees; Jesus Colino; Clifford M Snapper
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

5.  Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo.

Authors:  Swadhinya Arjunaraja; Lawrence C Paoletti; Clifford M Snapper
Journal:  J Immunol       Date:  2012-04-20       Impact factor: 5.422

6.  Immunosuppressive property within the Streptococcus pneumoniae cell wall that inhibits generation of T follicular helper, germinal center, and plasma cell response to a coimmunized heterologous protein.

Authors:  Swadhinya Arjunaraja; Lindsey Pujanauski; Jesus Colino; Raul M Torres; Clifford M Snapper
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

7.  PfbA, a novel plasmin- and fibronectin-binding protein of Streptococcus pneumoniae, contributes to fibronectin-dependent adhesion and antiphagocytosis.

Authors:  Masaya Yamaguchi; Yutaka Terao; Yuka Mori; Shigeyuki Hamada; Shigetada Kawabata
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

8.  Differential activation of inflammatory pathways in A549 type II pneumocytes by Streptococcus pneumoniae strains with different adherence properties.

Authors:  Rachel L Robson; Natalie A Reed; Rebecca T Horvat
Journal:  BMC Infect Dis       Date:  2006-04-11       Impact factor: 3.090

9.  Streptococcus iniae SF1: complete genome sequence, proteomic profile, and immunoprotective antigens.

Authors:  Bao-cun Zhang; Jian Zhang; Li Sun
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.